UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045158
Receipt number R000050642
Scientific Title Postoperative intraocular lens position in phaco-vitrectomy and phacoemulsification alone.
Date of disclosure of the study information 2021/08/15
Last modified on 2024/02/17 18:29:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Postoperative intraocular lens position in phaco-vitrectomy and phacoemulsification alone.

Acronym

Postoperative intraocular lens position

Scientific Title

Postoperative intraocular lens position in phaco-vitrectomy and phacoemulsification alone.

Scientific Title:Acronym

Postoperative intraocular lens position

Region

Japan


Condition

Condition

Cataract
Epiretinal/Epimacular membrane
Macular hole
Vitreomacular traction syndrome
Vitreous hemorrhage
Retinal detachment
Diabetic macular retinopathy
Central/Branch retinal vein occlusion
Subretinal hemorrhage
Vitreous opacity

Classification by specialty

Hepato-biliary-pancreatic medicine Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate and compare the intraocular lens position and refractive error after surgery in three groups (phacoemulification alone, phacovitrectomy without gas tamponade, and phacovitrectomy with gas tamponade) depending on the intraocular lens type.

Basic objectives2

Others

Basic objectives -Others

To evaluate the postoperative refractive error by surgical method and intraocular lens type.

Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The position of intraocular lenses at 6 month post-operation.


Key secondary outcomes

Lens position at 1 and 3 m postoperatively
Comparison of postoperative refractive error by IOLs
Comparison of postoperative refractive error by surgical procedure
Comparison of postoperative refractive error by type of gas tamponade
Comparison of postoperative refractive error by IOL power determination formula
Higher order aberrations (tilt/deviation) by IOL type
Comparison by disease
Comparison of the shape of the IOL optical cover by anterior capsule


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

1-piece acrylic lens (Clareon, Alcon co.)

Interventions/Control_2

3-piece acrylic lens (Avansee, Kowa co.)

Interventions/Control_3

3-piece larger optical diameter acrylic lens
((N)X-70, Santen co.)

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

Patients who have the following diseases and who need phacoemulification or phacovitrectomy with intraocular lens implantation.
1. Cataract
2. Epiretinal/Epimacular membrane
3. Macular hole
4. Vitreomacular traction syndrome
5. Vitreous hemorrhage
6. Retinal detachment
7. Diabetic macular retinopathy
8. Central/Branch retinal vein occlusion
9. Subretinal hemorrhage
10. Vitreous opacity

Key exclusion criteria

1. Patients with difficulty to be implanted intraocular lens fixation in the bag
2. Patients who implant an intraocular lens different from those used in this study.
3. Patients who hope to be implanted the specific intraocular lens.
4. Patients who should be implanted the specific intraocular lens.

Target sample size

360


Research contact person

Name of lead principal investigator

1st name Tatsushi
Middle name
Last name Kaga

Organization

Japan Community Healthcare Organization Chukyo Hospital

Division name

Ophthalmology

Zip code

4578510

Address

1-1-10 Sanjo, Minami-ku, Nagoya, Aichi

TEL

052-691-7151

Email

kaga@chukyogroup.jp


Public contact

Name of contact person

1st name Sho
Middle name
Last name Yokoyama

Organization

Japan Community Healthcare Organization Chukyo Hospital

Division name

Ophthalmology

Zip code

4578510

Address

1-1-10 Sanjo, Minami-ku, Nagoya, Aichi

TEL

052-691-7151

Homepage URL


Email

yokoyama@chukyogroup.jp


Sponsor or person

Institute

Japan Community Healthcare Organization Chukyo Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Community Healthcare Organization Chukyo Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Japan Community Healthcare Organization Chukyo Hospital Institutional Review Board

Address

1-1-10 Sanjo, Minami-ku, Nagoya, Aichi

Tel

052-691-7151

Email

rinrikanri@chukyo.jcho.go.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

2020053

Org. issuing International ID_1

Japan Community Healthcare Organization Chukyo Hospital Institutional Review Board

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 08 Month 15 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

90

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 06 Month 30 Day

Date of IRB

2021 Year 04 Month 05 Day

Anticipated trial start date

2021 Year 07 Month 01 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 08 Month 15 Day

Last modified on

2024 Year 02 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050642


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name